T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients

類似資料

• Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
  著者:: Andersen, Rikke, 等
  出版事項: (2014)
• Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
  著者:: Borch, Troels Holz, 等
  出版事項: (2020)
• BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer
  著者:: Donia, Marco, 等
  出版事項: (2012)
• mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma
  著者:: Borch, Troels Holz, 等
  出版事項: (2016)
• Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
  著者:: Borch, Troels Holz, 等
  出版事項: (2021)